www.fdanews.com/articles/192345-fda-clears-binx-health-diagnostic-for-stds
![ClearanceStamp_Orange.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Orange.gif?t=1609798625&width=430)
FDA Clears Binx Health Diagnostic for STDs
August 13, 2019
The FDA granted Binx Health another 510(k) clearance for its Binx io platform, clearing the fully automated point-of-care test for chlamydia and gonorrhea.
The test uses polymerase chain reaction (PCR) amplification and electrochemical testing to detect the common STDs.
It delivers results in about a half hour, using vaginal swab samples that can be collected by a physician or by the patient.